Rare diseases
Investigational molecules
Locations
Back to Greece978 clinical trials in Athens, Greece across 13 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study on Nipocalimab for Adults with Warm Autoimmune Hemolytic Anemia
GreeceStudy of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
GreeceStudy of Elranatamab, Dexamethasone, and Diphenhydramine Hydrochloride for Patients with High-Risk Smoldering Multiple Myeloma
GreeceStudy Comparing Talquetamab, Pomalidomide, and Teclistamab for Patients with Relapsed or Refractory Myeloma After 1 to 4 Prior Treatments
GreeceStudy of Isatuximab, Lenalidomide, and Dexamethasone for Patients with High-Risk Smoldering Multiple Myeloma
GreeceStudy on Long-Term Safety of Soticlestat for Patients with Dravet or Lennox-Gastaut Syndromes
GreeceStudy Comparing Entrectinib and Crizotinib for Patients with Advanced Non-Small Cell Lung Cancer with ROS1 Gene Changes, With or Without Brain Metastases
GreeceStudy on the Safety and Effectiveness of Pembrolizumab and Tretinoin in Patients with PD-1 Refractory Melanoma
GreeceStudy of Ibrutinib and Rituximab for Patients with Follicular Lymphoma
GreeceTitle: Comparison of oral tebipenem pivoxil versus intravenous imipenem-cilastatin in adults with complicated urinary tract infection or acute pyelonephritis
GreeceStudy on Hydroxychloroquine, Leflunomide, and Mycophenolate Mofetil for Patients with Primary Sjogren's Syndrome
GreeceStudy on the Safety of Tiragolumab and Atezolizumab for Patients with Advanced or Metastatic Solid Tumors
GreeceThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on head and neck cancer, bladder cancer, and advanced solid tumors. Research includes innovative combination therapies and novel treatment approaches for various tumor types.
Studies evaluate new therapeutic combinations and their impact on patient survival rates.
Investigations into treatments for various autoimmune disorders, including Sjögren's Syndrome, lupus, and inflammatory conditions.
Focus on developing targeted therapies for chronic autoimmune conditions.
Research examining treatments for heart failure, cardiovascular disease prevention, and metabolic disorders including obesity.
Trials evaluating new therapeutic approaches for cardiovascular risk reduction.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
